US Stock MarketDetailed Quotes

WST West Pharmaceutical Services

Watchlist
  • 225.950
  • -2.100-0.92%
Trading Mar 4 13:40 ET
16.34BMarket Cap33.77P/E (TTM)

About West Pharmaceutical Services Company

West Pharmaceutical Services, Inc. engages in the manufacture and marketing of pharmaceuticals, biologics, vaccines, and consumer healthcare products. It operates through the Proprietary Products and Contract-Manufactured Products segments. The Proprietary Products segment offers proprietary packaging, containment solutions and drug delivery products, along with analytical lab services, primarily to biologic, generic, and pharmaceutical drug customers. The Contract-Manufactured Products segment serves as a fully integrated business, focused on the design, manufacture, and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers. The company was founded by Herman O. West on July 27, 1923 and is headquartered in Exton, PA.

Company Profile

SymbolWST
Company NameWest Pharmaceutical Services
Listing DateJun 1, 1982
Issue Price16.00
Founded1923
CEOMr. Eric Mark Green
MarketNYSE
Employees10600
Fiscal Year Ends12-31
Address530 Herman O. West Drive
CityExton
ProvincePennsylvania
CountryUnited States of America
Zip Code19341-1147
Phone1-610-594-2900

Company Executives

  • Name
  • Position
  • Salary
  • Eric Mark Green
  • Chief Executive Officer, President and Chairman of the Board
  • 9.40M
  • Annette F. Favorite
  • Senior Vice President and Chief Human Resources Officer
  • --
  • Chad R. Winters
  • Vice President, Finance and Chief Accounting Officer
  • --
  • Bernard J. Birkett
  • Senior Vice President and Chief Financial Officer
  • 3.64M
  • Cindy Reiss-Clark
  • Chief Commercial Officer
  • 1.53M
  • Quintin J. Lai
  • Vice President, Strategy and Investor Relations
  • --
  • Kimberly Banks MacKay
  • Senior Vice President, General Counsel and Corporate Secretary
  • 1.49M
  • Janet Brutschea Haugen
  • Director
  • --
  • Robert F. Friel
  • Independent Director
  • 330.66K
  • Douglas A. Michels
  • Independent Director
  • 377.01K
  • Mark A. Buthman
  • Independent Director
  • 378.23K
  • Dr. Myla P. Lai-Goldman,M.D.
  • Independent Director
  • 359.35K
  • Molly E. Joseph
  • Independent Director
  • 321.43K
  • Dr. William F. Feehery, PhD
  • Independent Director
  • 362.83K
  • Paolo Pucci
  • Lead Independent Director
  • 367.44K
  • Thomas W. Hofmann
  • Independent Director
  • 390.35K
  • Deborah L.V. Keller
  • Independent Director
  • 333.45K
  • Dr. Stephen H. Lockhart, PhD
  • Independent Director
  • 331.46K

Trending Stocks

Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Discussing
Big Tech’s earnings season in full swing! Nvidia is the only one left
On Thursday, $Amazon (AMZN.US)$ stock fell after the firm reported Q4 adjusted earnings of $1.86/share, vs estimates of $1.50/share, on reve Show More